Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
12.09
+0.59 (5.13%)
At close: Jan 22, 2026, 4:00 PM EST
12.09
0.00 (0.00%)
After-hours: Jan 22, 2026, 6:30 PM EST
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2024. The number of employees decreased by 700 or -43.75% compared to the previous year.
Employees
900
Change (1Y)
-700
Growth (1Y)
-43.75%
Revenue / Employee
$876,556
Profits / Employee
$84,333
Market Cap
634.97M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 900 | -700 | -43.75% |
| Dec 31, 2023 | 1,600 | -900 | -36.00% |
| Dec 31, 2022 | 2,500 | 84 | 3.48% |
| Dec 31, 2021 | 2,416 | 216 | 9.82% |
| Dec 31, 2020 | 2,200 | 366 | 19.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 960 |
| Organogenesis Holdings | 869 |
| Pacira BioSciences | 790 |
| Kamada | 420 |
| Esperion Therapeutics | 304 |
| Ironwood Pharmaceuticals | 253 |
| Aquestive Therapeutics | 142 |
| BioAge Labs | 64 |
EBS News
- 7 days ago - NY Attorney General Sues Former Emergent BioSolutions CEO for Insider Trading - WSJ
- 7 days ago - Emergent BioSolutions Inc. (EBS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 10 days ago - Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation - GlobeNewsWire
- 14 days ago - Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026 - GlobeNewsWire
- 14 days ago - Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa - GlobeNewsWire
- 15 days ago - Emergent BioSolutions to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site - GlobeNewsWire
- 2 months ago - Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access - GlobeNewsWire